Sir John Chisholm, executive chair of Genomics England – a company set up and owned by the UK Department of Health to run the 100,000 Genomes Project, which aims to sequence 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer – discusses the company’s milestones, the role of the NHS, and where the UK stands in terms of medical research globally.
Can you introduce yourself and Genomics England to our international readers?
"By the time that my grandchildren approach my age, they will regard healthcare nowadays as no different from bleeding someone for a fever in the Middle Ages! Genomics will make today’s chemotherapy a therapy of the past."
